ECMO in paediatric septic shock: an urgent need for prospective trial

ECMO in paediatric septic shock: an urgent need for prospective trial

Bibliographic Details
Main Authors:	Xavier Beretta-Piccoli, Dominique Biarent, David De Bels, Patrick M. Honore, Sébastien Redant
Format:	Article
Language:	English
Published:	BMC 2020-03-01
Series:	Critical Care
Online Access:	http://link.springer.com/article/10.1186/s13054-020-2789-7

Similar Items

Impact of CRRT in Patients with PARDS Treated with VV-ECMO
by: Sébastien Redant, et al.
Published: (2021-03-01)

Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: the jury is still out
by: Xavier Beretta-Piccoli, et al.
Published: (2020-03-01)

Anti-Xa activity and hemorrhagic event: isn’t it time to consider time ?
by: Sébastien Redant, et al.
Published: (2021-06-01)

Urgent need for a randomized controlled trial with only septic patients!
by: Sébastien Redant, et al.
Published: (2019-10-01)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
by: Patrick M. Honore, et al.
Published: (2018-08-01)

Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
by: Patrick M. Honore, et al.
Published: (2019-12-01)

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
by: Patrick M. Honore, et al.
Published: (2020-09-01)

Early vs. late coronary angiography in cardiac arrest improves survival and preserves renal function: some confounding factors to consider
by: Sébastien Redant, et al.
Published: (2019-11-01)

Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
by: Patrick M. Honore, et al.
Published: (2020-07-01)

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
by: Patrick M. Honore, et al.
Published: (2020-07-01)

Is cortical perfusion a reliable marker for predicting septic acute kidney injury?
by: Patrick M. Honore, et al.
Published: (2019-03-01)

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Paediatrics: how to manage septic shock
by: Kam Lun Hon, et al.
Published: (2021-06-01)

Association between metformin use prior to admission and lower mortality in septic adult patients with diabetes mellitus: beware of potential confounders
by: Patrick M. Honore, et al.
Published: (2020-04-01)

Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
by: Patrick M. Honore, et al.
Published: (2021-03-01)

Do we need another prognostic score for cardiogenic shock patients with ECMO?
by: Sébastien Champion
Published: (2017-07-01)

Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
by: Patrick M. Honore, et al.
Published: (2020-10-01)

ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
by: Norbert Banjas, et al.
Published: (2018-12-01)

Candida infections in severe acute pancreatitis: we need to do more in order to distinguish invasive infection from simple colonization
by: Patrick M. Honore, et al.
Published: (2020-04-01)

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
by: Patrick M. Honore, et al.
Published: (2019-03-01)

Correction to: ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
by: Norbert Banjas, et al.
Published: (2019-01-01)

Quality of Life Following Urgent LVAD Implantation for ECMO Therapy in Cardiogenic Shock: A Long-Term Follow-Up
by: Rafal Berger, et al.
Published: (2021-07-01)

The challenge of removal of sepsis markers by continuous hemofiltration
by: Patrick M. Honore, et al.
Published: (2019-05-01)

Mechanism of arrhythmias during the infusion of Ringer’s acetate and Ringer’s lactate solutions during cardiac surgery: new insights
by: Sébastien Redant, et al.
Published: (2019-12-01)

Septic shock: ECMO beyond ARDS? Introducing the Simon two-stage protocol when randomisation is considered unethical
by: Alexander Buia, et al.
Published: (2020-03-01)

Preclinical septic shock research: why we need an animal ICU
by: Antoine Guillon, et al.
Published: (2019-06-01)

Successful Urgent TAVI for Critical Aortic Valve Stenosis after ECMO Implantation
by: Ya-Lei Niu, et al.
Published: (2022-02-01)

High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Angiotensin in ECMO patients with refractory shock
by: Marlies Ostermann, et al.
Published: (2018-11-01)

Should ECMO be used in cardiogenic shock?
by: Orhan Gokalp, et al.
Published: (2019-05-01)

Comparison of ECMO, IABP and ECMO + IABP in the Postoperative Period in Patients with Postcardiotomy Shock
by: Cagdas Baran, et al.
Published: (2024-09-01)

Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
by: Patrick M. Honore, et al.
Published: (2017-06-01)

Difference of 11 years between two periods of VV-ECMO does not impact mortality in large centres: we are not sure
by: Patrick M. Honore, et al.
Published: (2022-05-01)

Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
by: Patrick M. Honore, et al.
Published: (2020-03-01)

Influence of pathogen and focus of infection on procalcitonin values in sepsis: are there additional confounding factors?
by: Patrick M. Honore, et al.
Published: (2019-06-01)

Attainment of therapeutic vancomycin level within the first 24 h
by: Patrick M. Honore, et al.
Published: (2019-06-01)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
by: Patrick M. Honore, et al.
Published: (2019-05-01)

Adsorption and caspofungin dosing during continuous renal replacement therapy
by: Patrick M. Honore, et al.
Published: (2019-07-01)

New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
by: Patrick M. Honore, et al.
Published: (2020-02-01)

An unusual etiology of shock after ECMO decannulation
by: Pau Torrella, et al.
Published: (2024-08-01)